NCT05307328 — Cushing's Syndrome I trial site landscape

Public-registry site landscape for NCT05307328, a Cushing's Syndrome I study sponsored by Sparrow Pharmaceuticals. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT05307328 (registry record)
Sponsor	Sparrow Pharmaceuticals
Condition(s)	Cushing's Syndrome I; Cushing Disease Due to Increased ACTH Secretion; Cortisol Excess; Cortisol; Hypersecretion
Phase	PHASE2
Listed sites	12
Site countries	United States, Bulgaria, Romania

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT05307328 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →